Robert M. Gervis, Director at ASPEN AEROGELS INC (ASPN), bought 23,916 shares at $3.98 ($95K) on 2017-04-17, disclosed to the SEC on 2017-04-18.
Scheduled purchase ($95k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.98 | 3,599 | $14K | 15.0% |
| 2 | $3.98 | 3,606 | $14K | 15.1% |
| 3 | $3.99 | 8,311 | $33K | 34.8% |
| 4 | $3.99 | 8,400 | $34K | 35.1% |
| Total | $3.99 avg | 23,916 | $95K | 100% |
| Filing → |
| ASPN | BUY | 2017-05-08 | $3K | — | Filing → |
| ASPN | BUY | 2017-05-04 | $2K | — | Filing → |
| ASPN | BUY | 2017-05-02 | $1K | — | Filing → |